Biovie Cost Of Revenue from 2010 to 2025

BIVI Stock  USD 1.18  0.06  5.36%   
Biovie's Cost Of Revenue is increasing with slightly volatile movements from year to year. Cost Of Revenue is predicted to flatten to about 142.2 K. For the period between 2010 and 2025, Biovie, Cost Of Revenue quarterly trend regression had mean deviation of  114,233 and range of 266.8 K. View All Fundamentals
 
Cost Of Revenue  
First Reported
2016-12-31
Previous Quarter
57.3 K
Current Value
57.3 K
Quarterly Volatility
32.1 K
 
Covid
Check Biovie financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Biovie's main balance sheet or income statement drivers, such as Depreciation And Amortization of 193.4 K, Interest Expense of 3.5 M or Selling General Administrative of 10.7 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.12 or PTB Ratio of 2.3. Biovie financial statements analysis is a perfect complement when working with Biovie Valuation or Volatility modules.
  
Check out the analysis of Biovie Correlation against competitors.

Latest Biovie's Cost Of Revenue Growth Pattern

Below is the plot of the Cost Of Revenue of Biovie Inc over the last few years. Cost of Revenue is found on Biovie Inc income statement and represents the costs associated with goods and services Biovie provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities. It is Biovie's Cost Of Revenue historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Biovie's overall financial position and show how it may be relating to other accounts over time.
Cost Of Revenue10 Years Trend
Slightly volatile
   Cost Of Revenue   
       Timeline  

Biovie Cost Of Revenue Regression Statistics

Arithmetic Mean114,233
Geometric Mean0.00
Coefficient Of Variation105.78
Mean Deviation114,233
Median142,177
Standard Deviation120,841
Sample Variance14.6B
Range266.8K
R-Value0.82
Mean Square Error5B
R-Squared0.68
Significance0.000089
Slope20,901
Total Sum of Squares219B

Biovie Cost Of Revenue History

2025142.2 K
2024263.8 K
2022266.8 K
2021237.4 K
2018229.4 K

About Biovie Financial Statements

Investors use fundamental indicators, such as Biovie's Cost Of Revenue, to determine how well the company is positioned to perform in the future. Although Biovie's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Cost Of Revenue263.8 K142.2 K

Currently Active Assets on Macroaxis

When determining whether Biovie Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Biovie's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Biovie Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Biovie Inc Stock:
Check out the analysis of Biovie Correlation against competitors.
You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biovie. If investors know Biovie will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Biovie listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(3.25)
Return On Assets
(0.63)
Return On Equity
(1.55)
The market value of Biovie Inc is measured differently than its book value, which is the value of Biovie that is recorded on the company's balance sheet. Investors also form their own opinion of Biovie's value that differs from its market value or its book value, called intrinsic value, which is Biovie's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biovie's market value can be influenced by many factors that don't directly affect Biovie's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Biovie's value and its price as these two are different measures arrived at by different means. Investors typically determine if Biovie is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biovie's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.